Sidekick is a patient-centric digital care platform that is scalable across a wide range of chronic illnesses.
Sidekick is a patient-centric digital care platform that is scalable across a wide range of chronic illnesses. It delivers industry-leading retention and clinical impact on health outcomes including cardiovascular fitness, weight, blood glucose, quality of life, fatigue, and medication adherence. The Sidekick platform combines an evidence-based clinical approach with behavioral economics and gamification. It helps global customers like Pfizer and Bayer expand therapy reach and impact across multiple therapeutic areas and diseases, operating in multiple countries. The platform is a CE-marked, Class I Medical Device.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 5, 2022 | Series B | $55M | 4 | Novator | — | Detail |
Oct 28, 2020 | Series A | $20M | 4 | Asabys Partners Wellington Partners | — | Detail |
Aug 8, 2019 | Seed | kr100M | 1 | Novator | — | Detail |
Nov 19, 2018 | Seed | $5M | 1 | Novator | — | Detail |
Mar 15, 2017 | Seed | $1.50M | 1 | Frumtak Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Novator | Yes | Series B |
Technology Development Fund | Yes | Grant |
Asabys Partners | — | Series B |
Frumtak Ventures | — | Series B |
Wellington Partners | — | Series B |